Steven Robert Read

age ~79

from Saint Paul, MN

Get Report

Also known as:

Steven R Read
Angela L Read
Angela Larsen Read
Steve Robert Read
Steve R Read
Angie L Read

Connected to:

Steven Read Phones & Addresses

Saint Paul, MN
306 Marinette Trl, Madison, WI 53705 • 6082383986
Flint, MI
Denver, CO

Resumes

Artist

view source

Location:

Pittsburgh, PA

Industry:

Fine Art

Work:

Amc Theatres 2014 - Jun 2016
Bartender
Penn State University 2012 - 2014
Graduate Teaching Assistant
Barnes & Noble 2012 - 2014
Sales Associate
Prøve Gallery 2011 - 2012
Founder and Director
Penn State University 2012 - 2012
Instructor, Summer Art Camp

Education:

Penn State University 2012 - 2014
Masters, Studio Art, Sculpture University of Minnesota Duluth 2003 - 2011
Bachelors, Studio Arts, Design, Theatre, Ceramics, Sculpture

Skills:

Woodworking
Welding
Mig Welding
Stick Welding
Tig Welding
Hand Tools
Power Tools
Metal Work
Mold Making
Ceramic Sculpture
Photoshop
Rhino
Pepakura
123D Suite
Cnc Mill
Laser Cutting
Maker Bot
Arduino
Art Gallery
Art Curation
Art Installation
Adobe Creative Suite
Foundries
Wheel Throwing
Social Media
Microsoft Office
Event Planning
Customer Service
Research
Teaching
Photography
Social Networking
Sculpture
Fine Art

Languages:

English

Steven Read

view source

Owner At Read Construction

view source

Location:

Greater Minneapolis-St. Paul Area

Industry:

Construction

Name / Title

Company / Classification

Phones & Addresses

Steven Read
President

Dogo Dog Food Services Inc
Pet Transporting

PO Box 32110 RPO Westgate, Maple Ridge, BC V2X 0G9
6043412551

Steven Read
President

Dogo Dog Food Services Inc
Pet Transporting

6043412551

Us Patents

Sirna Targeting Kras
view source
US Patent:

7507811, Mar 24, 2009
Filed:

Dec 4, 2006
Appl. No.:

11/633306
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Littleton CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Stephen Scaringe - Lafayette CO, US
Steven Read - Denver CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C07H 21/04
C07H 21/02
A61K 48/00
US Classification:

536 245, 536 231, 536 243, 514 44
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

Sirna Targeting Myeloid Cell Leukemia Sequence 1
view source
US Patent:

7514550, Apr 7, 2009
Filed:

Sep 20, 2007
Appl. No.:

11/903001
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Littleton CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Stephen Scaringe - Lafayette CO, US
Steven Read - Denver CO, US
Assignee:

Dharmacon, Inc. - LaFayette CO
International Classification:

C07H 21/02
C07H 21/04
A61K 31/70
C12N 5/00
C12Q 1/68
US Classification:

536 245, 435 6, 536 231, 536 241, 514 44
Abstract:

Efficient sequence specific gene silencing of myeloid cell leukemia sequence 1 is possible through the use of siRNA technology. By selecting particular siRNAs directed to myeloid cell leukemia sequence 1 by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

Sirna Targeting Connexin 43
view source
US Patent:

7521191, Apr 21, 2009
Filed:

Mar 30, 2007
Appl. No.:

11/731894
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Conifer CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Steven Read - Denver CO, US
Stephen Scaringe - Lafayette CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C12Q 1/68
C07H 21/02
A61K 31/70
C12N 5/00
US Classification:

435 6, 536 231, 536 241, 536 245, 514 44
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to connexin 43 (gap junction protein alpha 1).

Sirna Targeting Aquaporin 4
view source
US Patent:

7541453, Jun 2, 2009
Filed:

Nov 9, 2006
Appl. No.:

11/598179
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Conifer CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Steven Read - Denver CO, US
Stephen Scaringe - Lafayette CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C07H 21/04
US Classification:

536 245
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.

Sirna Targeting Cell Division Cycle 20 Homolog (Cdc20)
view source
US Patent:

7550572, Jun 23, 2009
Filed:

Apr 9, 2007
Appl. No.:

11/784755
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Conifer CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Steven Read - Denver CO, US
Stephen Scaringe - Lafayette CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C07H 21/04
US Classification:

536 234
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CDC20.

Sirna Targeting Gremlin
view source
US Patent:

7569684, Aug 4, 2009
Filed:

Mar 30, 2007
Appl. No.:

11/731843
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Conifer CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Steven Read - Denver CO, US
Stephen Scaringe - Layfayette CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C07H 21/04
C07H 21/02
A61K 48/00
US Classification:

536 245, 536 231, 536 243, 514 44
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to CKSF1B1.

Sirna Targeting Transducin (Beta)-Like 3 (Tbl3)
view source
US Patent:

7576196, Aug 18, 2009
Filed:

Oct 14, 2008
Appl. No.:

12/287757
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Conifer CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Steven Read - Denver CO, US
Stephen Scaringe - Lafayette CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C07H 21/02
C07H 21/04
A61K 31/70
C12Q 1/68
US Classification:

536 245, 435 6, 536 231, 536 241, 514 44
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for TBL3.

Sirna Targeting Kras
view source
US Patent:

7576197, Aug 18, 2009
Filed:

Dec 9, 2008
Appl. No.:

12/330981
Inventors:

Anastasia Khvorova - Boulder CO, US
Angela Reynolds - Conifer CO, US
Devin Leake - Denver CO, US
William Marshall - Boulder CO, US
Stephen Scaringe - Lafayette CO, US
Steven Read - Boulder CO, US
Assignee:

Dharmacon, Inc. - Lafayette CO
International Classification:

C07H 21/04
C07H 21/02
A61K 48/00
US Classification:

536 245, 536 231, 514 44
Abstract:

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs directed to silencing KRAS, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.